Grand Rounds | 2023-2024

AN EDUCATION TRADITION OF THE TEXAS HEART INSTITUTE

Commitment to Learning & Professional Fellowship

Since its founding in 1962, The Texas Heart Institute has remained dedicated to improving the standard of care and advancing knowledge through cardiovascular education and research.  The Texas Heart Institute Grand Rounds is an esteemed tradition that attracts leading experts from around the world each year. Grand Rounds is hosted in the Denton A. Cooley Auditorium at 6770 Bertner Avenue in Houston, TX.

Series attendees include cardiology fellows and faculty, members of the Departments of Internal Medicine and Cardiovascular Surgery, as well as visitors from other clinical and teaching institutions in the Texas Medical Center. Grand Rounds is livebroadcasted for online viewing on any desktop computer or mobile device.  

A Continuing Medical Education Activity

Accreditation and Credit Designation

The Texas Heart Institute Cardiology Grand Rounds provides a weekly opportunity to learn from leading medical and surgical experts, sharing the latest advancements and innovations in the diagnosis, treatment, and prevention of cardiovascular disease. Located in the Denton A. Cooley Auditorium, The Institute offers CME credits for participation in Grand Rounds. Attendees can also log in from any computer, phone, or tablet to participate in the Live Webcast.


The Texas Heart Institute is accredited by the Accreditation Council or Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Heart Institute designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sept 29 | Adrian F. Hernandez, MD | Bending the Curve: Having the Trial Meet the Patient

Adrian F. Hernandez, MD | Bending the Curve: Having the Trial Meet the Patient

Bending the Curve: Having the Trial Meet the Patient

Adrian F. Hernandez, MD

Duke Health Cardiology Professor
Professor of Medicine
Duke University School of Medicine
Durham, NC

Overview:

Dr. Hernandez will describe the emerging forecast of problems in cardiovascular health, explain potential solutions, and describe how health systems and routine clinical care are a major part of the answer.

Objectives:

At the conclusion of the activity a participant should be able to:

• Describe emerging epidemiology of worsening cardiovascular health.
• Describe the challenges the US faces for evidence generation.
• Understand a range of solutions for better evidence generation.

Disclosures:

Dr. Hernandez has received research grants from and is a consultant for Boehringer Ingelheim, Bayer, Novo Nordisk, and Novartis.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Oct 13 | NO GRAND ROUNDS | Advances in Critical Care Conference

Oct 20 | David L. Brown, MD | A Simplified Physiology and Evidence Based Approach to Stable Angina

Oct 27 | Matthew W. Martinez, MD | Shared Decision Making in Athletes – Has the Data Changed the Sudden Cardiac Death Landscape?

Nov 3 | Jaime Hernandez-Montfort, MD | Heart Failure Related Cardiogenic Shock: Untangling the Spiral of Heterogeneity

Nov 3 | Jaime Hernandez-Montfort, MD | Heart Failure Related Cardiogenic Shock: Untangling the Spiral of Heterogeneity

Heart Failure Related Cardiogenic Shock: Untangling the Spiral of Heterogeneity

Jaime Hernandez-Montfort, MD

Baylor Scott & White Health
Austin, TX

Overview:

This lecture intends to describe the journey of heart failure related cardiogenic shock combining real-world data, programmatic growth and patient-centric interactions as a point of inflection in the development of clinical trials and early referral/transition strategies towards longitudinal well-being.

Objectives:

At the conclusion of the activity a participant should be able to:

• Identify distinct clinical and hemodynamic phenotypes of cardiogenic shock associated with heart failure.
• Recognize the programmatic impact of early detection and intervention in cardiogenic shock associated with heart failure.
• Explore distinct transition strategies in heart failure related cardiogenic shock towards native heart survival vs. replacement.

Disclosures:

Jaime Hernandez-Montfort, MD, is a consultant for Abiomed, Abbott, and Boston Scientific.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Nov 10 | Sean Palecek, PhD | Biomanufacturing Cardiac Cells from Human Pluripotent Stem Cells

Biomanufacturing Cardiac Cells from Human Pluripotent Stem Cells

Sean Palecek, PhD

Milton J. and Maude Shoemaker Professor and Vilas Distinguished Achievement Professor
Department of Chemical & Biological Engineering
University of Wisconsin – Madison

Overview:

This presentation will describe development of methods for differentiating human pluripotent stem cells to cardiomyocytes and other cardiac cell types to advance cardiac regenerative therapies.  Strategies to assess cell quality during manufacturing by multi-omic analysis of critical quality attributes will be discussed.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Describe processes for efficient and scalable manufacturing of cardiomyocytes from human pluripotent stem cells.
  • Determine critical quality attributes that predict the outcomes of a differentiation batch during manufacturing.
  • Identify strategies to control cardiovascular lineage progression during human pluripotent stem cell differentiation.

Disclosures:

Sean Palecek, PhD, has nothing to disclose relevant to this program.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Nov 17 | John P. Cooke, MD, PhD | Vascular Aging, Regeneration, and Cell Identity

Vascular Aging, Regeneration, and Cell Identity

John P. Cooke, MD, PhD

Joseph C. “Rusty” Walter and Carole Walter Looke Presidential Distinguished Chair in Cardiovascular Disease Research
Department of Cardiovascular Sciences
Houston Methodist Research Institute
Professor of Cardiovascular Sciences, Academic Institute
Director, Center for Cardiovascular Regeneration
Medical Director, Center for RNA Therapeutics Program
Houston Methodist DeBakey Heart and Vascular Center
Houston, Texas

Overview:

This presentation will describe how vascular senescence contributes to most age-related diseases; a dominant feature of vascular senescence is a loss of endothelial cell identity. Dr. Cooke will explain how this age-related endotheliopathy is defined by epigenetic, transcriptional and functional alterations that are reversible.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Describe the cellular and molecular hallmarks of aging.
  • State the features of endothelial senescence.
  • Describe the health-related implications of vascular aging.

Disclosures:

John P. Cooke, MD, PhD, is a Co-Founder at ChromeX Bio Inc., and PeakRNA Inc. He is also on the Scientific Advisory Board for Fibralign and Humann.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Dec 1 | Ryan Tedford, MD | Assessment of RV Reserve: Putting 'At Rest' Evaluations to Rest

Assessment of RV Reserve: Putting ‘At Rest’ Evaluations to Rest

Ryan Tedford, MD, FACC, FAHA, FHFSA

Dr. Peter C. Gazes Endowed Chair in Heart Failure
Professor of Medicine/Cardiology
Section Chief, Heart Failure
Medical Director, Cardiac Transplantation
Director, Advanced Heart Failure & Transplant Fellowship Training Program
Medical University of South Carolina (MUSC)

Overview:

Often largely ignored in the past, the right ventricle is now recognized as a major determinant of outcomes in a myriad of diseases. Dr. Tedford will illustrate how RV contractile impairment contributes to poor outcomes in patients with systemic sclerosis and discuss novel ways to assess RV function.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Describe a clinical observation (and ultimately an incorrect theory) that led us to investigate right ventricular loading conditions and RV contractility in systemic sclerosis.
  • Appraise emerging data on the role of RV reserve measurements including potential diagnostic and prognostic implications.
  • Illustrate how these techniques may predict and mitigate the risk of RV failure after LVAD implantation.

Disclosures:

Ryan Tedford, MD, FACC, FAHA, FHFSA, is a consultant for Abbott, Edwards, Merck, Medtronic, Aria, Acorai, Lexicon, Alleviant, CareDx, Cytokinetics, Gradient, United Therapeutics and Abiomed. He is also a steering committee member for Abbott, Edwards and Merck.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Dec 8 | Dawn E. Bowles, PhD | Gene Therapy for Cardiac Transplantation

 

Gene Therapy for Cardiac Transplantation

Dawn E. Bowles, PhD

Assistant Professor in Surgery
Duke University School of Medicine
Durham, NC

Overview:

Cardiac transplantation will benefit from application of gene therapy to prevent the onset of post-transplantation outcomes. This presentation will discuss recent advances in ex vivo perfusion for organ preservation and provide a means to overcome barriers to bringing gene therapy for cardiac transplantation into clinical practice. An overview of gene therapy research for cardiac transplantation will be provided.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Outline the 4 pillars required for successful gene therapy, using gene therapy for cardiac transplantation as an example.
  • Recognize that ex vivo perfusion enables efficient gene delivery to the heart.
  • Summarize the development of a preclinical porcine rejection model.

Disclosures:

Dawn Bowles, PhD, received research support from Solid Biosciences, and provision of devices and consumables in kind from Transmedics. She is a stockholder of AskBio.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Dec 15 | Daniella Kadian-Dodov, MD, FACC, FAHA, FSVM, RPVI | Fibromuscular Dysplasia: Looking Beyond the String-of-Beads

 

Fibromuscular Dysplasia: Looking Beyond the String-of-Beads

Daniella Kadian-Dodov, MD

Associate Professor of Medicine – Vascular Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Overview:

Dr. Kadian-Dodov will review the expanding phenotype of fibromuscular dysplasia with focus on manifestations of spontaneous artery dissection and other vascular events.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Identify patients in whom the diagnosis of FMD should be considered.
  • Integrate a practical approach to the evaluation and management of patients with FMD and related arteriopathies based on the available evidence.

Disclosures:

Daniella Kadian-Dodov, MD, received honoraria from Boston Scientific and Abbott; she is an advisor for Boston Scientific. She also received research support to Mount Sinai Fuster Heart Hospital from Philips Healthcare.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Jan 12 | Gary Roubin, MD, PhD | Ray C. Fish Award for Scientific Achievement | Carotid Stenting: State of the Art

 

Carotid Stenting: State of the Art

Gary S. Roubin, MD, PhD

Jackson, Wyoming

Please Note: No CME or MOC Credit will be provided for this lecture.

Jan 19 | Jagat Narula, MD, PhD | Can We Eliminate Heart Attacks in Our Lifetime?

Can We Eliminate Heart Attacks in Our Lifetime?

Jagat Narula, MD, PhD

Executive Vice President and Chief Academic Officer
UTHealth Houston

K. Lance Gould Distinguished University Chair in Coronary Pathophysiology
McGovern Medical School
UTHealth Houston
Houston, Texas

President Elect, World Heart Federation

Overview:

Dr. Narula will discuss how to eliminate heart attacks in our lifetime by targeting plaques, treating patients, or tweaking the population.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Discuss the importance of anatomic extent of coronary stenosis, functional relevance of the degree of ischemia, and the pathological characteristics of the plaque and the vessel.
  • Discuss the role of imaging modalities in assessment of eventful coronary lesions.
  • Discuss the possible therapeutic strategies targeted at the plaque, patient, and population level.

Disclosures:

Jagat Narula, MD, PhD, has nothing to disclose relevant to this program.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Jan 26 | K. Lance Gould, MD | PET Guided Randomized CENTURY Trial and Interventions in Complex CAD

PET Guided Randomized CENTURY Trial and Interventions in Complex CAD

K. Lance Gould, MD

Professor, Cardiovascular Medicine
Martin Bucksbaum Distinguished University Chair in Cardiovascular Medicine
Department of Internal Medicine
UTHealth McGovern Medical School

Medical and Executive Director, Weatherhead PET Imaging Center for Preventing and Reversing Atherosclerosis
The University of Texas Health Science Center at Houston
Houston, Texas

Overview:

The positron emission tomography (PET) guided randomized CENTURY Trial showed significantly reduced death, myocardial infarction, revascularizations, and MACE over 11-year follow-up. Coronary Flow Capacity by PET reveals limited improvement in myocardial perfusion and survival probability after revascularization due to residual coronary artery disease (CAD), incomplete revascularization or progression of CAD, better after coronary artery bypass graft (CABG) than percutaneous coronary intervention (PCI). Virtual survival probability after hypothetical revascularization predicts actual survival probability after actual revascularization for guiding optimal patient selection and procedures for complex or post-revascularization residual CAD.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Apply clinical coronary pathophysiology as fundamental in daily cardiology practice.
  • Utilize cardiac PET as the most advanced technology for managing complex CAD optimally evolved to accomplish the aims below for advancing invasive cardiology from its scientifically limited interventional protocols into more effective, safer, less costly practice.
  • Discuss why regional, artery-specific size severity of Coronary Flow Capacity should replace all diagnostic coronary angiograms and proceed all revascularization for evidence-based guidance to improve survival, relieve angina and minimize non-beneficial high-risk process based on randomized trial and a 10,000-case cohort followed for 14 years for outcomes.

Disclosures:

K. Lance Gould, MD, has nothing to disclose relevant to this program.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Feb 2 | Joseph S. Galati, MD, FACG, FAASLD | Metabolic Dysfunction-Associated Steatotic Liver Disease: A New Paradigm for Cardiovascular Care

Metabolic Dysfunction-Associated Steatotic Liver Disease: A New Paradigm for Cardiovascular Care

Joseph S. Galati, MD, FAASLD, FACG 

Director, Liver Specialists of Texas

Medical Director
Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Houston Methodist
Houston, Texas

Overview:

Dr. Galati will discuss how non-alcoholic fatty liver disease affects between 8-100 million adults in America. The vast majority of these patients are obese with complications of metabolic syndrome. While progressive liver disease leading to cirrhosis and liver cancer are serious complications, the leading cause of death in this cohort of patients is cardiovascular disease.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Explain the epidemiology and risk factors for fatty liver disease.
  • Discuss the natural history, evaluation, and management of fatty liver disease.
  • Compare the overlap of cardiovascular risk factors and complications related to metabolic dysfunction-associated steatotic liver disease.

Disclosures:

Joseph S. Galati, MD, FAASLD, FACG, has nothing to disclose relevant to this program.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Feb 9 | David S. Ludwig, MD, PhD | Carbohydrate-Insulin Model of Obesity

Carbohydrate-Insulin Model of Obesity

David S. Ludwig, MD, PhD

Professor of Pediatrics, Harvard Medical School
Professor of Nutrition, Harvard School of Public Health
Endocrinologist and Researcher, Boston Children’s Hospital
Boston, Massachusetts

Overview:

Dr. Ludwig will contrast competing models of obesity pathogenesis, examine evidence from multiple lines of investigation pertaining to these models, and consider implications to public health and clinical care.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Summarize scientific evidence in conflict with the conventional Energy Balance Model of Obesity.
  • Highlight the fundamental components of the Carbohydrate-Insulin Model.
  • Discuss implications of the Carbohydrate-Insulin Model to public health and clinical care.

Disclosures:

David Ludwig, MD, PhD, has nothing to disclose relevant to this program.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Feb 16 | NO GRAND ROUNDS | Perioperative MCS Symposium

Feb 23 | Anita Deswal, MD, MPH, MBBS | Cardiovascular Effects of Immune Checkpoint Inhibitors for Cancer: Myocarditis and Beyond

 

Cardiovascular Effects of Immune Checkpoint Inhibitors for Cancer: Myocarditis and Beyond

Anita Deswal, MD, MPH, MBBS

Professor of Medicine
Department Chair, Medicine
Ting Tsung and Wei Fong Chao Distinguished Chair
Department of Cardiology
Division of Internal Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas

Overview:

The use of immunotherapy with immune checkpoint inhibitors has revolutionized the treatment of several cancers and their use is increasing exponentially. However, they are associated with several immune-related adverse events including those of the cardiovascular system. The presentation will describe the current state of knowledge about cardiovascular effects of immune checkpoint inhibitors as can be encountered by all cardiologists.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Recognize the presentation of patients with immune checkpoint related myocarditis.
  • Select diagnostic and therapeutic strategies for immune checkpoint related myocarditis.
  • Appreciate the potential for longer term cardiovascular effects of immune checkpoint inhibitors.

Disclosures:

Anita Deswal, MD, MPH, MBBS, has nothing to disclose relevant to this program.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Mar 1 | William E. Cohn, MD | Past, Present and Future of the Total Artificial Heart: A Very Houston-Centric Story

Past, Present and Future of the Total Artificial Heart: A Very Houston-Centric Story

William E. Cohn, MD

Director, Center for Device Innovation at the Texas Medical Center
Professor of Surgery, Transplant and Assist Devices, Baylor College of Medicine
Adjunct Professor of Bioengineering, University of Houston
Adjunct Professor of Bioengineering, Rice University
Adjunct Professor of Bioengineering, Texas A&M University
Cardiothoracic Surgery, The Texas Heart Institute Academic Professional Staff
Houston, Texas

Mar 8 | Roger S. Blumenthal, MD | 34th Annual Edward Dennis Memorial Lecture | Raging Controversies in CV Prevention

Raging Controversies in CV Prevention

Roger S. Blumenthal, MD

Professor of Medicine
Kenneth Jay Pollin Professor of Cardiology
Director, Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease
Johns Hopkins Medicine
Baltimore, Maryland

Overview:

Dr. Blumenthal will examine the raging controversies in cardiovascular risk assessment and in the primary prevention of cardiovascular disease.

Objectives:

At the conclusion of the activity a participant should be able to:

  • Examine the evidence supporting the selective use of cardiac computed tomography (CT) to improve cardiovascular risk prediction and guide medical management.
  • Compare and contrast the AHA/ACC guidelines with the new ESC guidelines that deal with diabetes and heart failure prevention.
  • Discuss comprehensive preventive cardiology care using an ABCDE approach.

Disclosures:

Roger S. Blumenthal, MD, has nothing to disclose relevant to this program.

The Planning Committee has nothing to disclose relevant to this program.

The Texas Heart Institute CME Staff has nothing to disclose relevant to this program.

The Program Reviewers have nothing to disclose relevant to this program.

All relevant financial relationships have been mitigated.

Accreditation

The Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Texas Heart Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Successful completion is a passing grade of 70% on the assessment in the CME evaluation.

CME credits & MOC points must be claimed within 24 hours after a live conference.

Mar 15 | Sanjiv Narayan, MD, PhD

Mar 22 | Christopher M. O’Connor, MD, MACC, FHFSA, FHFA

Apr 5 | Joseph A. Hill, MD

Apr 12 | Timothy D. Henry, MD, MSCAI | 21st Annual John Lewis Lecture | Options for the No-Option Patient: Treatment of Refractory Angina in 2024

Options for the No-Option Patient: Treatment of Refractory Angina in 2024

Timothy D. Henry, MD, MSCAI

Lindner Family Distinguished Chair in Clinical Research
Medical Director, The Carl and Edyth Lindner Center for Research
The Christ Hospital
Cincinnati, Ohio

Apr 19 | NO GRAND ROUNDS | Houston Echo Review

Apr 26 | Cezar Iliescu, MD, FACC, FSCAI

May 3 | Jon A. Kobashigawa, MD | 38th Annual Don Chapman Lecture

Jon A. Kobashigawa, MD

Director, Advanced Heart Disease and
The Heart Transplant Program
Smidt Heart Institute, Cedars-Sinai
Los Angeles, CA

May 10 | Shreela Sharma, PhD, RDN, LD

Shreela Sharma, PhD, RDN, LD

Director, Center for Health Equity
Professor & Vice Chair
Department of Epidemiology, Human Genetics & Environmental Sciences
UTHealth School of Public Health
The University of Texas Health Science Center at Houston
Houston, TX

Distinguished Teaching Professor
The University of Texas System

May 17 | James McCabe, MD, FACC

May 31 | Joseph G. Rogers, MD | The Texas Heart Institute – A Year in Review